ATXN3 and Spinocerebellar ataxia type 3: Using PC12 cells transfected with expanded ATX3 as a model of MJD, treatment with 10μM CoQ10 was shown to improve cell viability, reduce the percentage of apoptotic cells, and prevent ATX3 protein aggregation ultimately ameliorating MJD-like pathologies (Table 1).